Monterey Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Monterey Private Wealth’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,487	Closed	-$337K	–	102
2021 Q2	$337K	Hold	2,487	–	–	0.19%	68
2021 Q1	$347K	Hold	2,487	–	–	0.19%	59
2020 Q4	$350K	Hold	2,487	–	–	0.2%	57
2020 Q3	$277K	Hold	2,487	–	–	0.18%	62
2020 Q2	$278K	Buy	+2,487	New	+$245K	0.2%	56
2020 Q1	–	Sell	-2,487	Closed	-$237K	–	84
2019 Q4	$237K	Buy	+2,487	New	+$215K	0.19%	71

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Monterey Private Wealth's XBI Position: Q3 2021 in Review

Monterey Private Wealth sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2021, closing a stake of 2,487 shares — an estimated $337K sold.

Monterey Private Wealth first reported a position in XBI in Q4 2019 and held it in 6 quarters. The position peaked at $350K in Q4 2020. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

Monterey Private Wealth reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2021 after selling out during the quarter.
Monterey Private Wealth sold 2,487 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $337K.
Monterey Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and held it in 6 quarters.
Monterey Private Wealth's State Street SPDR S&P Biotech ETF position peaked at $350K in Q4 2020.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on Monterey Private Wealth's 13F filing for Q3 2021, filed 8 Oct 2021.